Parag Saxena 13D and 13G filings for Reviva Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-31 9:31 pm Purchase | 2024-12-18 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | Parag Saxena | 6,268,906 12.400% | 17,300 (+0.28%) | Filing |
| 2024-08-23 4:07 pm Purchase | 2024-08-22 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | Parag Saxena | 6,251,606 16.900% | 6,251,606 (New Position) | Filing |